Cash Logistics Market Is Expected To Accomplish A Valuation Of Around USD 46.36 Billion By 2030: Grand View Research Inc.

 Cash Logistics Market Growth & Trends

The global cash logistics market size is anticipated to reach USD 46.36 billion by 2030, registering a CAGR of 8.2% from 2022 to 2030, according to a new report by Grand View Research Inc. The growing demand for efficient cash management solutions such as intelligent vaults and fully automated cash-in-transit vehicles to enhance operational functionality and flexibility are the major factors driving the growth of the market.

In addition, the growing need for security in currency handling activities is expected to gain high momentum over the forecast period. The rising integration of Artificial Intelligence (AI) into cash management solutions to prevent fraud is also expected to contribute to the growth of the market. Several biometric solution providers are focusing on developing new features and functions, such as secure software for efficient cash management solutions and automatic cash handling services for better security.

Companies such as Brink's Incorporated, CMS Info Systems Ltd., and Prosegur Cash SA have developed AI-based solutions to enhance the customer experience as per the changing needs of customers. Cash management solution providers are acquiring ATM service-providing companies to expand their reach. For instance, in April 2021, Brink's Company, a cash management solution company, announced the acquisition of PAI, Inc., a U.S.-based privately-owned ATM services provider, for USD 213 million to expand its reach in the U.S.

Advanced technologies complement the benefits of cash-in-transit vehicles. Several vehicle manufacturers are developing electric armored money transporter for the safety of employees. For instance, in August 2020, MAN, a commercial vehicle provider, introduced a MAN eTGE electric van, an electrically armored money transporter, to Prosegur, an international security service provider. The COVID-19 pandemic has adversely impacted the growth of the cash logistics industry owing to the supply chain disruptions.

However, cash logistics companies are recovering and are focusing on integrating advanced functionalities and features into their products to attract customers and expand their client base. Additionally, technological advancements have led to the development of contactless ATMs, which are marketed as a risk-free way of withdrawing cash amid the COVID-19 Pandemic. Such technological advancements are expected to boost the adoption of ATMs, which, in turn, is anticipated to propel market growth over the forecast period.

Request a free sample copy or view report summary: Cash Logistics Market Report

Cash Logistics Market Report Highlights

• Cash-in-transit held the largest share in the service segment owing to the pursuance of standard protocols for safe transportation coupled with a rising trend of outsourcing banking activities
• The cash management services segment is expected to emerge as the fastest growing service segment owing to the rise in demand for handling cash within the retail segment
• The financial institutions segment is expected to continue its dominance over the forecast period owing to the growing adoption of cash logistics solutions among financial institutions on account of benefits such as customization of solutions, improved transparency, and optimal currency flow, among others
• Various factors, such as increasing purchasing power coupled with the accelerated growth in the installation of ATMs in emerging countries such as China and India, are significantly contributing to the Asia Pacific regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cash-logistics-market

Cash Logistics Market Segmentation

Grand View Research has segmented the global cash logistics market based on services, end use, and region.

Cash Logistics Service Outlook (Revenue, USD Billion, 2017 - 2030)

• ATM Services
• Cash-in-transit
• Cash management
• Others

Cash Logistics End Use Outlook (Revenue, USD Billion, 2017 - 2030)

• Financial Institutions
• Government Agencies
• Retail
• Others

Cash Logistics Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the Cash Logistics Market

• Brink's Incorporated
• Cash Logistik Security AG
• CMS Info Systems Ltd.
• G4S Limited
• GardaWorld
• Global Security Logistic Co.
• Security and Intelligence Services Ltd.
• Loomis AB
• Prosegur
• Cash in Transit Solutions Pty Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Manual Resuscitators Market to Partake Significant Development During 2022 to 2030: Grand View Research Inc.

 Manual Resuscitators Market Growth & Trends

The global manual resuscitators market size is expected to reach USD 799.3 million by 2030, expanding at a CAGR of 5.67% during the forecast period, according to a new report by Grand View Research, Inc. The demand for manual resuscitators/ Bag Valve Mask (BVM) is expected to grow owing to the rising cases of COPD and the increasing need for neonatal ventilation.

Moreover, the increasing obese population is likely to increase the risk of cardiac arrest cases, in turn driving the demand for artificial ventilation. According to National Health and Nutrition Examination Survey (NHANES) data of 2017-2018, 2 in 5 adults suffer from obesity, which accounts for almost 44% of the U.S. population. According to World Health Organization (WHO), in 2020, around 39 million children suffered from obesity under the age of 5.

The rising mortality due to non-communicable diseases, such as coronary heart disease has created a pressing need to increase awareness about the measures to be taken to help a patient. Countries such as Germany, the U.K., and France are undertaking initiatives to create awareness amongst people about CPR and heart problems. According to the World Health Organization (WHO), approximately 41 million people die every year due to non-communicable diseases. Cardiovascular disease accounts for around 17.9 million deaths every year. This is projected to bode well with the market. 

To address the growing death rate from cardiac arrest, organizations such as the American Heart Association, Red Cross, and Resuscitation Council (U.K., Australia, and Europe), also assist the countries to increase the survival rates of sudden cardiac arrest. These activities include providing training to perform artificial ventilation, providing resuscitation kits, and encouraging bystanders to help patients in emergency cases.

Moreover, the COVID-19 pandemic has positively impacted the market owing to the huge requirement of oxygen and owing to the lack of supply of ventilators. Manual resuscitators were in huge demand as a portable replacement for the ventilators.  For instance, the demand for Ambu’s resuscitators and single-use scopes was greater during the pandemic. Ambu’s witnessed 21% organic revenue growth in the Q3 of 2020.

Request a free sample copy or view report summary: Manual Resuscitators Market Report

Manual Resuscitators Market Report Highlights

• Based on type, the self-inflating segment accounted for the maximum market share in 2021 as they have greater usability in emergency situations, where bystander cardiopulmonary resuscitation is necessary. Companies are striving to launch newer integrated products, which can help in overcoming the delayed ventilation issues.
• The flow-inflating segment also referred to as anesthesia bags is expected to witness a rapid rise in demand since they are majorly used in ICUs, where 100% oxygen delivery is of utmost importance. The increasing birth rate and increasing efforts by global organizations such as UNICEFs to curb neonatal deaths at the time of birth in low-resource nations are further expected to propel the segment growth in the coming years.
• In terms of end-use, the hospital segment dominated the market in 2021 due to the requirement for artificial ventilation in the delivery and neonatal ward. With the increasing admission of cardiac arrest patients, the need for resuscitators is expected to further increase.
• There has been a global increase in the number of out-of-hospital cardiac arrests globally. Each year about 326,000 cases of cardiac arrest occur outside the hospital setting which accounts for the major cause of death in the U.S. and around 200,000 cardiac arrests occur in hospitals. This is contributing to the expansion of the out-of-hospital segment.
• North America dominated the market in 2021. The introduction of state-of-the-art resuscitation products and training kits to reduce the chances of delayed ventilation are the major drivers of the market.
• Asia Pacific is expected to witness significant growth during the forecast period attributed to the rising incidence rate of heart diseases and the huge untapped market. The advancement in neonatal intensive care in low and middle-income countries, such as Pakistan, Bangladesh, and India is less. Each year, out of 3.0 million neonatal deaths globally, around 1 million occur in South-East Asia. This unmet patient population need is anticipated to render substantial growth to the market in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-manual-resuscitators-market

Manual Resuscitators Market Segmentation

Grand View Research has segmented the global manual resuscitators market based on type, modality, material, technology, patient type, end-use, application, and region:

Manual Resuscitator Type Outlook (Revenue, USD Million, 2017 - 2030)

• Self-inflating Resuscitator
• Flow-inflating Resuscitator
• T-piece

Manual Resuscitator Modality Outlook (Revenue, USD Million, 2017 - 2030)

• Disposable
• Reusable

Manual Resuscitator Material Outlook (Revenue, USD Million, 2017 - 2030)

• Silicon
• PVC
• Rubber

Manual Resuscitator Technology Outlook (Revenue, USD Million, 2017 - 2030)

• Pop-off valve
• PEEP Valve
• Others

Manual Resuscitator Patient Type Outlook (Revenue, USD Million, 2017 - 2030)

• Adult
• Pediatric
• Others

Manual Resuscitator Application Outlook (Revenue, USD Million, 2017 - 2030)

• Chronic Obstructive Pulmonary Disease
• Cardiopulmonary Arrest
• Others

Manual Resuscitator End-Use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospital
• Out-of-hospital
• ASC
• Military
• Others

 Manual Resuscitator Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players in the Manual Resuscitators Market

• WEINMANN Emergency Medical Technology GmbH + Co. KG
• Laerdal Medical
• Ambu A/S
• Medline Industries, LP
• Hopkins Medical Product
• ResMed, Inc.
• HUM Gesellschaft für Homecare und Medizintechnik mbH
• PERSYS MEDICAL
• CareFusion

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Breast Reconstruction Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 Breast Reconstruction Market Growth & Trends

The global breast reconstruction market size is expected to reach USD 826.9 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2022 to 2030. Rising cases of breast cancer, an increase in the number of reconstructive procedures, and rising awareness regarding the availability of breast reconstruction procedures are expected to be the key factors driving the market.

According to the National Breast Cancer Foundation, around 55 Australians are diagnosed with breast cancer every day. Moreover, as per a similar source, one in every seven women is expected to be diagnosed with breast cancer once in a lifetime. Similarly, according to World Life Expectancy, deaths due to breast cancer in Mexico tallied up to 1.20% of the total deaths in the country. Thus, due to an increase in the number of breast cancer patients, the market is expected to witness growth over the coming years.

Similarly, as per the NCBI, the rate of breast reconstruction post-mastectomy is rising continuously in the U.S. Moreover, according to a study published by a similar source in 2018, the number of breast reconstructions has been increasing since 2005. For instance, the number of breast reconstructions has increased from 4% in 2005 to 38.3% in 2014. This is expected to boost the market growth.

The COVID-19 pandemic was anticipated to restrict the growth of the market. However, the market is projected to witness growth during the post-pandemic period. The growth can be accredited to various product launches, geographic expansion, partnerships, and various strategic initiatives by major market players. For instance, in September 2021, Establishment Labs, launched a tissue expander, “Motiva Flora” in Europe and other CE mark countries to gain share in the market.

Request a free sample copy or view report summary: Breast Reconstruction Market Report

Breast Reconstruction Market Report Highlights

• On the basis of product, the implants segment dominated the market with a revenue share of over 60.0% in 2021. The tissue expander segment is projected to register the fastest growth rate over the forecast period
• Based on shape, the round shape segment dominated the market in 2021. The anatomical shape segment is expected to register the fastest growth rate of 8.7% over the forecast period
• By end-use, the hospitals segment held the largest revenue share of over 45.0% in 2021. The ASCs segment is projected to register the fastest growth rate in the forecast period. This can be attributed to the rising number of reconstruction surgeries in ambulatory surgical centers
• North America dominated the market with a revenue share of over 40.0% in 2021. Asia Pacific is projected to witness the fastest growth over the forecast period. This can be accredited to a rise in the number of breast cancer patients and increasing awareness regarding the availability of breast reconstruction procedures in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-breast-reconstruction-market

Breast Reconstruction Market Segmentation

Grand View Research, Inc. has segmented the global breast reconstruction market on the basis of product, shape, end-use, and region:

Breast Reconstruction Product Outlook (Revenue, USD Million, 2018 - 2030)

• Implants
  • Silicone Breast Implants
  • Saline Breast Implants
• Tissue Expander
  • Saline Expander
  • Air Tissue Expander
• Acellular Dermal Matrix

Breast Reconstruction Shape Outlook (Revenue, USD Million, 2018 - 2030)

• Round Shape
• Anatomical Shape

Breast Reconstruction End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers

Breast Reconstruction Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Breast Reconstruction Market

• Johnson & Johnson
• Allergan Inc.
• Sientra Inc.
• Ideal Implant Incorporated
• Establishment Labs S.A.
• POLYTECH Health & Aesthetics GmbH
• RTI Surgical Holdings
• Sebbin
• Integra LifeSciences
• GC Aesthetics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medication Management System Market Overview, Analysis And Forecast To 2030: Grand View Research Inc.

 Medication Management System Market Growth & Trends

The global medication management system market size is expected to reach USD 6.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2022 t0 2030. Rise in the number of prescriptions globally, increase in investments by hospitals for workflow management, advanced technologies, and rise in government reforms and policies boosting the integration of IT in healthcare are estimated to drive market growth. 

Rise in challenges faced by healthcare professionals for efficient management of clinical operations, streamlined workflow, and reduced healthcare costs drive the demand for automated solutions in healthcare facilities. Rapid growth in prescriptions has increased the burden on care providers to efficiently manage prescriptions of patients and minimize medication errors. Thus, increase in the number of prescriptions is one crucial factor driving the market growth. In addition, a shortage of pharmacists and healthcare professionals will further boost the adoption of IT solutions in healthcare facilities.

The market had a positive impact during the pandemic. COVID-19 sickness began to spread over the world in early 2020, infecting millions of people globally, and major countries around the world-imposed foot restrictions and work stoppage orders. To assist control the spread of the infection, social distance and lockdowns were employed. Patients with chronic diseases unable to access healthcare facilities for routine treatment and medication administration suffered. Except for the medical supply and life support goods businesses, most industries have been severely hit, and have also been severely impacted.

There is a rise in investments by hospitals to streamline clinical processes and they have been purchasing new software to manage workflow, which is expected to boost the market growth. For instance, in March 2017, Saudi German Hospital-Dubai automated its medication management workflow by integrating Omnicell’s solutions. According to WHO, chronic diseases including cancer, diabetes, and cardiovascular disease accounted for approximately 73% of global death in 2020, this will generate a necessity for long-term medication with efficient dispensing and continuous patient monitoring, which can be accomplished effectively through medication management systems.

Also, according to a 2017 report by WHO, medication errors cost USD 42 billion per year globally. According to these numbers, there is a raising need for medication management systems as an essential component of comprehensive healthcare infrastructure. The population is at risk of adverse drug events due to the possibility of human error in delivering medication, which can be reduced by employing a medication management system. This would boost the worldwide medication management system market growth.

Reforms, policies, and initiatives are being taken by governments to increase the adoption of healthcare IT across the globe, which is expected to drive market growth. For instance, the German National Medication Plan is an initiative directed toward enhancing medication management software in hospitals and pharmacies in Germany.

To extend the geographic reach and client bases, key market players are using competitive strategies such as technology advancement, acquisitions and mergers, agreements, collaboration, and partnerships. For instance, in March 2022, Constellation Software, through N. Harris Computer (subsidiary), concluded its agreement for the acquisition of a net asset of Allscripts Healthcare Solutions’ hospitals and large physician practices business for a payment of USD 700 million in cash.

Request a free sample copy or view report summary: Medication Management System Market Report

Medication Management System Market Report Highlights

• The inventory management solutions segment held a majority of revenue share in the market in 2021 due to the rising need to reduce issues such as stockout and overstock
• The hospitals segment held the largest revenue share in 2021 owing to the rise in investments by hospitals to upgrade their IT infrastructure
• The cloud-based solutions segment dominated the market owing to greater data security
• North America dominated the market owing to high adoption of healthcare IT and technological advancements

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medication-management-system-market

Medication Management System Market Segmentation

Grand View Research has segmented the global medication management market on the basis of software, service, mode of delivery, end use, and region:

Medication Management System Software Outlook (Revenue, USD Million, 2016 - 2030)

• Computerized Physician Order
• Clinical Decision Support System Solutions
• Inventory Management Software
• Administration Software
  • Electronic Medication Administration Record (EMAR)
  • Barcode Medication Administration (BMA)
• Automated Dispensing Systems
  • Centralized
    • Robots
    • Carousels
  • Decentralized
    • Pharmacy-based ADS
    • Ward-based ADS
    • Automated Unit-Dose Dispensing
  • Assurance System Software
  • Other Software

Medication Management System Services Outlook (Revenue, USD Million, 2016 - 2030)

• Medication Analytics
• Point-of-Care Verification
• ADE Surveillance

Medication Management System Mode of Delivery Outlook (Revenue, USD Million, 2016 - 2030)

• On-premises
• Web-based
• Cloud-based

Medication Management System End-Use Outlook (Revenue, USD Million, 2016 - 2030)

• Hospitals
• Pharmacy
• Others

Medication Management System Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Medication Management System Market

• Allscripts
• Becton
• Dickinson and Company (CareFusion)
• GE Healthcare
• Talyst, LLC.
• McKesson Corporation
• Cerner Corporation
• QuadraMed Affinity Corporation
• Omnicell, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cash Logistics Market Is Expected To Accomplish A Valuation Of Around USD 46.36 Billion By 2030: Grand View Research Inc.

 Cash Logistics Market Growth & Trends

The global cash logistics market size is anticipated to reach USD 46.36 billion by 2030, registering a CAGR of 8.2% from 2022 to 2030, according to a new report by Grand View Research Inc. The growing demand for efficient cash management solutions such as intelligent vaults and fully automated cash-in-transit vehicles to enhance operational functionality and flexibility are the major factors driving the growth of the market.

In addition, the growing need for security in currency handling activities is expected to gain high momentum over the forecast period. The rising integration of Artificial Intelligence (AI) into cash management solutions to prevent fraud is also expected to contribute to the growth of the market. Several biometric solution providers are focusing on developing new features and functions, such as secure software for efficient cash management solutions and automatic cash handling services for better security.

Companies such as Brink's Incorporated, CMS Info Systems Ltd., and Prosegur Cash SA have developed AI-based solutions to enhance the customer experience as per the changing needs of customers. Cash management solution providers are acquiring ATM service-providing companies to expand their reach. For instance, in April 2021, Brink's Company, a cash management solution company, announced the acquisition of PAI, Inc., a U.S.-based privately-owned ATM services provider, for USD 213 million to expand its reach in the U.S.

Advanced technologies complement the benefits of cash-in-transit vehicles. Several vehicle manufacturers are developing electric armored money transporter for the safety of employees. For instance, in August 2020, MAN, a commercial vehicle provider, introduced a MAN eTGE electric van, an electrically armored money transporter, to Prosegur, an international security service provider. The COVID-19 pandemic has adversely impacted the growth of the cash logistics industry owing to the supply chain disruptions.

However, cash logistics companies are recovering and are focusing on integrating advanced functionalities and features into their products to attract customers and expand their client base. Additionally, technological advancements have led to the development of contactless ATMs, which are marketed as a risk-free way of withdrawing cash amid the COVID-19 Pandemic. Such technological advancements are expected to boost the adoption of ATMs, which, in turn, is anticipated to propel market growth over the forecast period.

Request a free sample copy or view report summary: Cash Logistics Market Report

Cash Logistics Market Report Highlights

• Cash-in-transit held the largest share in the service segment owing to the pursuance of standard protocols for safe transportation coupled with a rising trend of outsourcing banking activities
• The cash management services segment is expected to emerge as the fastest growing service segment owing to the rise in demand for handling cash within the retail segment
• The financial institutions segment is expected to continue its dominance over the forecast period owing to the growing adoption of cash logistics solutions among financial institutions on account of benefits such as customization of solutions, improved transparency, and optimal currency flow, among others
• Various factors, such as increasing purchasing power coupled with the accelerated growth in the installation of ATMs in emerging countries such as China and India, are significantly contributing to the Asia Pacific regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cash-logistics-market

Cash Logistics Market Segmentation

Grand View Research has segmented the global cash logistics market based on services, end use, and region.

Cash Logistics Service Outlook (Revenue, USD Billion, 2017 - 2030)

• ATM Services
• Cash-in-transit
• Cash management
• Others

Cash Logistics End Use Outlook (Revenue, USD Billion, 2017 - 2030)

• Financial Institutions
• Government Agencies
• Retail
• Others

Cash Logistics Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the Cash Logistics Market

• Brink's Incorporated
• Cash Logistik Security AG
• CMS Info Systems Ltd.
• G4S Limited
• GardaWorld
• Global Security Logistic Co.
• Security and Intelligence Services Ltd.
• Loomis AB
• Prosegur
• Cash in Transit Solutions Pty Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Smokeless Cigarettes Market Growth With Worldwide Industry Analysis To 2030: Grand View Research Inc.

 Smokeless Cigarettes Market Growth & Trends 

The global smokeless cigarettes market size is expected to reach USD 93.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.0% from 2022 to 2030. The growing concerns over the harmful effect of tobacco-based cigarettes among various age groups have increased the demand for relatively less-toxic e-cigarettes and vape products, which is expected to bolster the market growth. According to an article published in BMJ Journal in 2019, approximately 20.8% of U.S. youth and 4.5% of U.S. adults are current e-cigarette users.

Furthermore, COVID-19-based marketing and digital sales strategies post-pandemic is also expected to support the market growth. According to an article published in Campaign for Tobacco-Free Kids, in May 2020, various e-cigarettes maker and vape shops promoted their products by offering free giveaways such as protective masks and 19% off nicotine e-liquids by entering the code COVID-19. Therefore, over the forecast period, the use of vape devices is expected to increase, especially among recreational smokers and smokers working to stop smoking altogether.

The electric segment was the largest revenue-generating segment in 2021 and is expected to maintain dominance in the forecast period. The increasing adoption of trendy lifestyles among consumers has led to the growth of smokeless cigarettes and other related products and forms. According to an article published in KPI6, in July 2021, approximately 64% of men are primarily involved in the conversation about e-cigarettes and vaping. Another key factor contributing to the rapid growth of e-cigarettes is the consumer shift from nicotine-based products to smoke-free cigarettes, which is expected to accelerate the market growth.

The offline distribution channel dominated the market in 2021. The convenient shopping experience of having various products, forms, and flavors of e-cigarettes in a single place is the primary driver for consumers to visit their nearby stores including supermarkets, hypermarkets, convenience stores, and others. Furthermore, the allowance of consumers to first check and then buy these devices through the above-mentioned stores will help the segment adapt well to the market growth.

Major players in the market include a combination of a few established players and many small players. Some of these are JUUL Labs Inc, British American Tobacco Plc, RELX Technology Co Ltd, Imperial Brands Plc, Japan Tobacco Inc, Shenzhen Joye Technology Co Ltd, Shenzhen IVPS Technology Co Ltd, Shenzhen Kanger Technology Co Ltd, Shenzhen Eigate Technology Co Ltd, Flavourart srl. Key players in this market face intense competition from each other as some of them are among the top manufacturers and have a large customer base for their products in both regional and international markets. 

Request a free sample copy or view the report summary: Smokeless Cigarettes Market Report

Smokeless Cigarettes Market Report Highlights

• North America dominated the market and accounted for the largest revenue share in 2021. The increasing launches of flavored cigarettes in the U.S. will support the market in the region
• The electric segment is projected to register faster growth during the forecast period as these products have advanced and programmable functions, such as temperature control
• The online segment is predicted to become the fastest growing segment during the forecast period owing to easy doorstep delivery services

Access Press Release@ https://www.grandviewresearch.com/press-release/global-smokeless-cigarettes-market

Smokeless Cigarettes Market Segmentation

Grand View Research has segmented the global smokeless cigarettes market based on product, distribution channel, and region:

Smokeless Cigarettes Product Outlook (Revenue, USD Million, 2017 - 2030)

• Non-electric
• Electric

Smokeless Cigarettes Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Smokeless Cigarettes Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • New Zealand
  • Philippines
• Central & South America
• Middle East & Africa
  • UAE
  • South Africa

List of Key Players in Smokeless Cigarettes Market

• JUUL Labs Inc.
• British American Tobacco Plc
• RELX Technology Co Ltd.
• Imperial Brands Plc
• Japan Tobacco Inc.
• Shenzhen Joye Technology Co. Ltd.
• Shenzhen IVPS Technology Co. Ltd.
• Shenzhen Kanger Technology Co. Ltd.
• Shenzhen Eigate Technology Co. Ltd.
• Flavourart Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceutical Third-party Logistics Market Trends Analysis And Forecast Till 2030: Grand View Research Inc.

 Biopharmaceutical Third-party Logistics Market Growth & Trends

The global biopharmaceutical third-party logistics market size is expected to reach USD 198.5 billion by 2030, growing at a CAGR of 5.9% over the forecast period, according to a new report by Grand View Research, Inc. The rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the biopharmaceutical third-party logistics (3PL) market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend in the pharmaceutical logistics companies that have gained significant traction. The key market players played a vital role in the fight against COVID-19 by minimizing supply disruptions and prioritizing critical care drugs.

A sudden surge in the demand for cold chain logistics was observed during the pandemic because of the manufacturing and distribution of COVID-19 vaccines. The future also seems good for the global market with the rising demand for domestic logistics coupled with favorable government initiatives and policies. Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines, and biologics, is projected to drive the market. Since these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus is responsible for the market growth.

Moreover, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Request a free sample copy or view the report summary: Biopharmaceutical Third-party Logistics Market Report

Biopharmaceutical Third-party Logistics Market Report Highlights

• In 2021, the non-cold chain segment held the largest revenue share owing to the sales of a large number of drugs that do not require any temperature control
• The cold chain logistics segment is expected to register the fastest CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
• The warehousing and storage service types segment accounted for the largest market share in 2021
• Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period
• This is mainly attributed to the rising demand for medicines from the aging population and the shift of drug sales from brand manufacturers to generic

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-third-party-logistics-3pl-market

Biopharmaceutical Third-party Logistics Market Segmentation

Grand View Research has segmented the global biopharmaceutical third-party logistics market based on the supply chain, service type, and region:

Biopharmaceutical 3PL Supply Chain Outlook (Revenue, USD Billion, 2018 - 2030)

• Cold Chain
• Non-cold Chain

Biopharmaceutical 3PL Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing & Storage
• Others Services

Biopharmaceutical 3PL Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Biopharmaceutical Third-party Logistics Market

• FedEx
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corp.
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Ltd.
• Agility

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America, Europe & Asia Pacific Legal Cannabis Market Expected To Propel Industry Growth By 2030: Grand View Research Inc.

 North America, Europe & Asia Pacific Legal Cannabis Market Growth & Trends

The North America, Europe, and Asia Pacific legal cannabis market size is expected to reach USD 89.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. As more individuals become aware of the medical benefits of hemp, marijuana, and its derivatives, and as these products become more generally available, acceptance is expanding. Another key factor boosting market expansion is the increased acceptance of medicinal marijuana for the treatment of chronic diseases. Legalizing marijuana for adult use in many countries will assist in creating new job possibilities and add significantly to the economy. Tourism, real estate, finance, food, and transportation are just a few of the industries that will benefit from legalization. Manufacturers are facing challenges in setting up a functional and legalized channel for the development and trade of cannabis-derived products like cannabidiol due to the presence of strict laws.

The marijuana product segment led the market with a revenue share of over 70.0% in 2021. Marijuana for medical purposes is increasing in popularity as a result of recent legalizations in a number of nations. Patients with chronic diseases like Parkinson's disease, cancer, arthritis, Alzheimer's disease, and neurologic issues like depression, anxiety, and epilepsy are treated with marijuana. As a result, one of the primary reasons behind the expansion of this market is the widespread use of marijuana for the treatment of numerous chronic illnesses.

The CBD derivatives segment accounted for the largest revenue share in 2021 owing to the vast applications of these derivatives. It is extensively being used for medicinal purposes as well as for the cosmetic industry. In the APAC region, the cosmetic industry is a huge business and there has been a surge in the use of CBD derivatives in various skincare products. The others segment, being the fastest-growing category, is seeing an upward trend due to the increasing number of studies proving their prowess in the medical field.

The medical use segment emerged as the largest end-use segment in 2021. As medical cannabis is allowed in more countries than adult-use cannabis, the medical sector is likely to stay dominant during the forecast period. The increasing usage of cannabis and its derivatives in a variety of applications, including medicines, nutraceuticals, personal care and cosmetics, and edibles, is expected to increase the demand for these goods.

With a revenue share of over 80.0% in 2021, North America led the market. The availability of a large customer pool in the region and the early legalization of marijuana for medical and recreational use are major factors driving the market. Asia Pacific is predicted to be the fastest-growing market from 2022 to 2030 owing to the increased understanding of cannabis' medical and health benefits, which has prompted Asian countries to legalize cannabis and its derivatives.

During the pandemic, lockdowns and transit disruptions produced a disturbance in product supply, increasing the supply-demand disparity. As a result, the localized market and the worldwide market have been hampered. As customers gravitate away from traditional treatment approaches and move toward cannabis-based treatment, increased use of marijuana, largely for medicinal purposes, boosts the total market growth. Furthermore, the COVID-19 pandemic has significantly impacted the legal cannabis industry as a statewide lockdown has interrupted product production and imposed import/export restrictions, resulting in lower total revenue.

Request a free sample copy or view the report summary: North America, Europe & Asia Pacific Legal Cannabis Market Report

North America, Europe & Asia Pacific Legal Cannabis Market Report Highlights

• The market growth can be attributed to the greater use of hemp and marijuana products and increasing preference for medical marijuana. In addition, the upcoming legalization of marijuana for adult use is expected to boost growth over the predicted period
• Due to the increased acceptance of marijuana for various medical illnesses, marijuana emerged as the leading source type in 2021
• By end-use, the medical use segment held the largest revenue share in 2021. This is due to an increase in the product's use for chronic pain, mental illnesses such as anxiety, and sleep difficulties and increased knowledge among practitioners
• Owing to the increasing consumption rate as a result of legalization, North America accounted for the largest revenue share in 2021

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-europe-asia-pacific-legal-cannabis-market-analysis

North America, Europe & Asia Pacific Legal Cannabis Market Segmentation

Grand View Research, Inc. has segmented the North America, Europe, and Asia Pacific legal cannabis market based on source type, derivatives, end-use, and region:

North America, Europe & Asia Pacific Legal Cannabis End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Marijuana
  • Flower
  • Oil & Tinctures
• Hemp
  • Hemp CBD
  • Supplements
  • Industrial Hemp

North America, Europe & Asia Pacific Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2017 - 2030)

• CBD
• THC
• Others

North America, Europe & Asia Pacific Legal Cannabis End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Medical Use
  • Cancer
  • Chronic Pain
  • Depression and Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s
  • Post-Traumatic Stress Disorder (PTSD)
  • Parkinson's
  • Tourette’s
  • Others
• Recreational Use
• Industrial Use
  • Textile
  • Non-textile

North America, Europe & Asia Pacific Legal Cannabis Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Czech Republic
  • Switzerland
• Asia Pacific
  • Australia
  • New Zealand
  • Thailand
  • Japan
  • South Korea

List of Key Players of North America, Europe & Asia Pacific Legal Cannabis Market

• CANOPY GROWTH CORPORATION
• Aurora Cannabis
• Tilray
• GW Pharmaceuticals, plc
• Organigram Holdings Inc
• Lexaria Bioscience Corp.
• VIVO Cannabis Inc.
• The Cronos Group
• AusCann Group Holdings Ltd.
• Cann Group Limited
• Bod Australia
• Zelira Therapeutics
• Althea Group
• THC Global Group Limited
• MGC Pharma
• ECOFIBRE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Breast Cancer Drug Market is Projected to Boost USD 38.4 Billion by 2025: Grand View Research Inc.

 The global breast cancer drug market size is expected to reach USD 38.4 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.7% during the forecast period. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends stoking market growth.

Global breast cancer drugs market is expected to grow lucratively as many players focus majorly on R&D of innovative treatments. They engage in extensive research to develop novel drugs for the treatment of the disease to gain a higher market share. There exists a growing pressure and need for novel therapies and treatment due to rapidly accelerating prevalence of diseases. The strong pipeline is expected to provide new and effective treatment options and improved outcomes than existing therapies.

With advancements in drug delivery systems, various target specific therapies have been customized and designed as a carrier to infuse the therapeutic agent to the target site. Carriers for inducing target therapy include modified anticancer agent’s specific to molecular-recognition-element, anticancer peptides, and nanoparticle-based anticancer drugs. For instance, HER2/neu protein is usually given in combination with other anti-cancer drugs in targeted therapy.

1. Hoffman-La Roche Ltd leads the breast cancer drugs market with Herceptin, Perjeta, and Kadcyla. However, rapid advancements in biosimilarswith a goal to offer cost effective alternatives to patients is anticipated to put pressure on this space. For instance, in December 2017, the Food and Drug Administration (FDA) approved the first biosimilar of trastuzumab for HER2+ breast cancer.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/breast-cancer-drugs-market

Further key findings from the report suggest:

• HER2 inhibitors is expected to be the most preferred drug class segment over the forecast period, owing to their high specificity as they are subclass of target therapy
• CDK 4/6 inhibitor is expected to be the fastest growing segment over the forecast period. There are currently more than 45 CDK 4/6 inhibitor drug candidates in pipeline
• North America held the largest market share in 2017 owing to the factors such as the presence of key manufacturers in the country, high awareness and adoption, and well-established healthcare infrastructure among others
• Europe was estimated to be the second largest regional segment in 2017 due to increasing incidence of breast cancer and growing R&D investments
• Asia Pacific is anticipated to witness healthy growth over the next decade due to increasing incidence of breast cancer, rise in awareness about early diagnosis in emerging countries such as China and India.
• Companies such as F. Hoffmann-La Roche Ltd; Pfizer Inc.; AstraZeneca; Novartis AG; Astellas Pharma Inc.; and Eli Lilly and Company dominated the breast cancer drugs market
• The market is lucrative and competitive in nature as manufacturers engage in new product development to increase their product penetration. Moreover, they are entering into collaborations and partnerships to enhance their product portfolio.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-breast-cancer-drugs-market

Grand View Research has segmented the global breast cancer drugs market on the basis of type and region:

Breast Cancer Drug Type Outlook (Revenue, USD Million, 2014 - 2025)

• HER2 Inhibitors
• Mitotic Inhibitors
• Anti-metabolites
• Aromatase Inhibitors
• CDK 4/6 Inhibitors
• Hormonal Receptor

Breast Cancer Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Silicone Elastomers Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Silicone Elastomers Market Growth & Trends

The global silicone elastomers market size is expected to reach USD 12.5 billion by 2030, according to a new study by Grand View Research, Inc. The market is projected to advance at a CAGR of 10.3% from 2022 to 2030. The growing population, rising disposable income, and rapid industrialization and urbanization in the developing regions are some of the key factors that are presumed to drive the regional markets. R&D initiatives to develop superior-quality robust products that have a wide application base across diverse industries offer ample opportunities for market development.

A surge in demand for properties such as extended lifetime, efficient performance over a wide range of temperatures, low toxicity, low flammability, low smoke density, inertness to chemicals & solvents, oil & fuel resistance, and high productivity is anticipated to be beneficial for the overall market advancement. The increasing scope of silicone elastomers in the healthcare industry is expected to have a positive impact on the market.

Some of the notable applications of silicone elastomers in the medical industry include catheters, tubing, medical cables, seals & gaskets, membranes, O-rings, valves, respiratory care applications, anesthetic masks, medical instruments & equipment, and medical textile coatings. Such a wide range of applications is touted to create ample opportunities for the silicone elastomers industry in the coming years.

The market for silicone elastomers has been classified into three segments, on the basis of product, application, and region. Major silicone elastomer products include high-temperature vulcanize (HTV), room temperature vulcanize (RTV), and liquid silicone rubber (LSR). HTV has dominated the market demand in the last few years. Room temperature vulcanize is slated to witness the highest growth rate during the forecast period.

Some of the prominent applications of silicone elastomers include electrical & electronics, automotive & transportation, industrial machinery, consumer goods, and construction, among others. The construction application segment dominated the global market in 2021, ahead of the automotive, and electrical & electronics segments. Other applications such as medical & healthcare and cosmetics are anticipated to experience the highest CAGR during the forecast period.

Regionally, the market has been segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America occupied a significant market share in the recent past. However, this region, along with Western Europe, is expected to lose substantial market share and witness sluggish growth in the next seven years. Emerging markets such as the Asia Pacific are touted to witness the highest demand in the near future. Economies such as China, India, and Southeast Asian countries are projected to lead the regional market.

Request a free sample copy or view report summary: Silicone Elastomers Market Report

Silicone Elastomers Market Report Highlights

• Asia Pacific dominated the overall market and is expected to advance at the fastest CAGR of 10.6% in terms of revenue during the forecast period
• LSR was estimated to be the largest product segment in the global market for silicone elastomers in 2021 and is also anticipated to dominate the market during the projection period
• Construction accounted for the largest revenue share of more than 43% in the application segment of the global market for silicone elastomers in 2021 and is also anticipated to dominate the market in the projection period
• Silicone elastomers have widespread applications in the medical and healthcare industry. Starting from medical equipment to drug delivery systems, silicone elastomers have gained acceptance in this industry fairly rapidly. Such acceptance can be attributed to favorable properties such as inertness, high permeability, easy processing, and low toxicity

Access Press Release@ https://www.grandviewresearch.com/press-release/global-silicone-elastomers-market

Silicone Elastomers Market Segmentation

Grand View Research has segmented the global silicone elastomers market on the basis of product, application, and region:

Product Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• HTV
• RTV
• LSR

Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Electrical & Electronics
• Automotive & Transportation
• Industrial Machinery
• Consumer Goods
• Construction
• Others

Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
• Europe
  • Germany
  • France
  • UK
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players in the Silicone Elastomers Market

• China National BlueStar (Group) Co., Ltd.
• Dow Corning Corporation
• KCC Corporation
• Mesgo S.P.A.
• Momentive Performance Materials Inc.
• Shin-Etsu Chemical Co., Ltd.
• Reiss Manufacturing Inc.
• Wacker Chemie AG
• Zhejiang Xinan Chemical Industrial Group Co., Ltd.
• Stockwell Elastomerics
• Specialty Silicone Products, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.